MAPT and Alzheimer disease: Therefore, in this study, we have analyzed and compared the PTMs in the pathological tau proteins prepared from a wide range of tauopathies (AD, PSP, CBD, GGT, PiD, and FTDP-17T with MAPT intron 10 mutation) in order to establish whether the PTMs show disease-specificity.